EP3703747
Notkun á NOX4 eða NOX4/1 hindra í samsetningu með ónæmismeðferðarmiðli til meðhöndlunar á krabbameini
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.11.2018EP published:
3.9.2025EP application number:
18800871.8
EP translation filed:
18.12.2025Grant published:
14.1.2026EPO information:
European Patent Register
Max expiry date:
31.10.2038Expiry date:
31.10.2026Next due date:
30.11.2026
Title in English:
USE OF A NOX4 OR NOX4/1 INHIBITOR IN COMBINATION WITH AN IMMUNOTHERAPEUTIC AGENT FOR THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
1.11.2018EP application
3.9.2025EP Publication
18.12.2025Translation submitted
14.1.2026Registration published
31.10.2026Expires
Owner
Name:
Calliditas Therapeutics Suisse SAAddress:
chemin des Aulx 14, 1228 Plan-les-Ouates, CH
Name:
University Of SouthamptonAddress:
University Road, Southampton, Hampshire SO17 1BJ, GB
Inventor
Name:
WIESEL, PhilippeAddress:
75017 Paris, FR
Name:
HEITZ, FreddyAddress:
1233 Bernex, CH
Name:
THOMAS, GarethAddress:
Burley Hampshire BH24 4BA, GB
Name:
HANLEY, ChristopherAddress:
Southampton Hampshire SO15 8AN, GB
Name:
FORD, KirstyAddress:
Weymouth Dorset DT4 7RB, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17199601Date:
1.11.2017Country:
EP
Classification
Categories:
A61K 31/437, A61K 39/395, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 19.12.2025
Expires: 31.10.2026
Payer: iPify